Drug Discovery

e-Therapeutics plc is a drug discovery and development company. It pioneered and exploits network pharmacology to evaluate swiftly and accurately how medicines interact with cells in the body. This approach optimises the probability of identifying drug candidates with desirable efficacy and minimal side effects.

Network pharmacology can be applied to many disease areas, and is particularly suited to addressing complex diseases in which current treatment options are few and poor. The company’s current drug discovery programmes are focused mainly on areas of high unmet medical need, such as neurodegeneration and oncology.

Four drugs resulting from the Company's earlier discovery projects are now in clinical development.